中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2012年
4期
263-265
,共3页
流感病毒A型,人%供血者%流感疫苗%免疫,主动
流感病毒A型,人%供血者%流感疫苗%免疫,主動
류감병독A형,인%공혈자%류감역묘%면역,주동
Influenza A virus,human%Blood donors%Influenza vaccine%Immunity,active
目的 评价无偿献血者接种甲流疫苗的持续免疫效果及未接种甲流疫苗献血者的甲流抗体水平,为防治甲流提供参考依据.方法 应用ELISA法检测2010年1-6月1166例东莞市接种甲流疫苗及1265例未接种甲流疫苗的无偿献血者的甲流抗体.结果 接种甲流疫苗献血者的平均甲流抗体的阳性率及高效价率为78.82％与46.57％,两者在71～90 d达到峰值后维持在较高水平.未接种甲流疫苗献血者的平均甲流抗体阳性率为26.01％；在性别、年龄组别之间差异无统计学意义(P＞0.05).结论 甲流疫苗的持续免疫效果良好,对于甲流的防治有重要作用.未接种甲流疫苗献血者的甲流抗体阳性率低,应加强接种工作.
目的 評價無償獻血者接種甲流疫苗的持續免疫效果及未接種甲流疫苗獻血者的甲流抗體水平,為防治甲流提供參攷依據.方法 應用ELISA法檢測2010年1-6月1166例東莞市接種甲流疫苗及1265例未接種甲流疫苗的無償獻血者的甲流抗體.結果 接種甲流疫苗獻血者的平均甲流抗體的暘性率及高效價率為78.82％與46.57％,兩者在71～90 d達到峰值後維持在較高水平.未接種甲流疫苗獻血者的平均甲流抗體暘性率為26.01％；在性彆、年齡組彆之間差異無統計學意義(P＞0.05).結論 甲流疫苗的持續免疫效果良好,對于甲流的防治有重要作用.未接種甲流疫苗獻血者的甲流抗體暘性率低,應加彊接種工作.
목적 평개무상헌혈자접충갑류역묘적지속면역효과급미접충갑류역묘헌혈자적갑류항체수평,위방치갑류제공삼고의거.방법 응용ELISA법검측2010년1-6월1166례동완시접충갑류역묘급1265례미접충갑류역묘적무상헌혈자적갑류항체.결과 접충갑류역묘헌혈자적평균갑류항체적양성솔급고효개솔위78.82％여46.57％,량자재71～90 d체도봉치후유지재교고수평.미접충갑류역묘헌혈자적평균갑류항체양성솔위26.01％；재성별、년령조별지간차이무통계학의의(P＞0.05).결론 갑류역묘적지속면역효과량호,대우갑류적방치유중요작용.미접충갑류역묘헌혈자적갑류항체양성솔저,응가강접충공작.
Objective To access the sustained immune effect in influenza A H1N1 vaccine vaccinated-blood donors as well as the level of anti-H1N1 IgG in unvaccinated-blood donors in order to provide reference for preventing and treating influenza A H1N1.Methods Anti-H1N1 IgG was detected in 1166 vaccinated-blood donors as well as 1265 unvaccinated-blood donors by ELISA method in Dongguan from January 2010 to June 2010.Results The mean positive rate and high-titer rate of anti-H1N1 IgG were 78.82％ and 46.57％ respectively,both of which were sustained at relatively high level after reaching their peak at vaccination time of 71-90 d.The mean positive rate of anti-H1N1 IgG in unvaccinated-blood donors was 26.01％.No difference was found in the positive rate of anti-H1N1 IgG among different gender or age groups( P ＞0.05).Conclusion The influenza A H1N1 vaccine,with good sustained immune effect,plays an important role in preventing and treating influenza A H1N1.The positive rate of anti-H1N1 IgG in influenza A H1N1 vaccine unvaccinated-blood donors is low.Vaccination should be strengthened.
